Add Yahoo as a preferred source to see more of our stories on Google. Two neurons, one showing damage to it's myelin sheath, from MS There may be two distinct subtypes of multiple sclerosis, according ...

Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.